Nutrition in Alcoholic Liver Disease

Clinics in Liver Disease

Volumn 16, Issue 4, 2012, Pages 805-826

  Singal, Ashwani K ^a   Charlton, Michael R ^a  

^a MAYO CLINIC   (United States)

Author keywords

Alcohol; Cirrhosis; Metabolism; Nutrition

Indexed keywords

ALANINE AMINOTRANSFERASE; ALCOHOL; ALPHA TOCOPHEROL; ANTIOXIDANT; AROMATIC AMINO ACID; ASCORBIC ACID; ASPARTATE AMINOTRANSFERASE; BRANCHED CHAIN AMINO ACID; CALCIUM; COLLAGEN; CREATININE; CYANOCOBALAMIN; FOLIC ACID; GLUCOSE; GLUTATHIONE; HOMOCYSTEINE; IRON; MAGNESIUM; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINIC ACID; OXANDROLONE; PHOSPHOROUS ACID; PREDNISOLONE; PYRIDOXINE; RETINOL; SELENIUM; THIAMINE; UNINDEXED DRUG; VITAMIN D; ZINC;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL LIVER CIRRHOSIS; ALCOHOL LIVER DISEASE; ALCOHOL METABOLISM; ALPHA TOCOPHEROL DEFICIENCY; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD BRAIN BARRIER; BODY WEIGHT; BONE DENSITY; CARBOHYDRATE METABOLISM; CHOLESTEROL DIET; CLINICAL PRACTICE; COFFEE; COMPUTER ASSISTED TOMOGRAPHY; CREATININE BLOOD LEVEL; DIET SUPPLEMENTATION; DIETARY INTAKE; DISEASE COURSE; DISEASE SEVERITY; ENERGY EXPENDITURE; ENTERIC FEEDING; FATTY ACID METABOLISM; FOLIC ACID DEFICIENCY; FOOD INTAKE; GASTROINTESTINAL ABSORPTION; GASTROINTESTINAL MUCOSA; GRIP STRENGTH; HAND GRIP; HOSPITALIZATION; HUMAN; HYPERMETABOLISM; KIDNEY FUNCTION; LIVER FAILURE; LIVER FIBROSIS; MUSCLE STRENGTH; NUTRITIONAL ASSESSMENT; NUTRITIONAL STATUS; NUTRITIONAL SUPPORT; OXIDATIVE STRESS; PARENTERAL NUTRITION; PROTEIN CALORIE MALNUTRITION; PROTEIN INTAKE; PROTEIN RESTRICTION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETINOL DEFICIENCY; REVIEW; STEATORRHEA; TREATMENT DURATION; TREATMENT INDICATION; VITAMIN METABOLISM; WERNICKE ENCEPHALOPATHY; ZINC DEFICIENCY;

DIETARY SUPPLEMENTS; HUMANS; LIVER DISEASES, ALCOHOLIC; MALNUTRITION; NUTRITION ASSESSMENT; NUTRITION DISORDERS; NUTRITION THERAPY; NUTRITIONAL STATUS;

EID: 84867938636     PISSN: 10893261     EISSN: 15578224     Source Type: Journal    
DOI: 10.1016/j.cld.2012.08.009     Document Type: Review

References (127)

1. Mendenhall C.L., Moritz T.E., Roselle G.A., et al. Protein energy malnutrition in severe alcoholic hepatitis: diagnosis and response to treatment. The VA Cooperative Study Group #275. JPEN J Parenter Enteral Nutr 1995, 19:258-265.
2. Cheung K., Lee S.S., Raman M. Prevalence and mechanisms of malnutrition in patients with advanced liver disease, and nutrition management strategies. Clin Gastroenterol Hepatol 2012, 10:117-125.
3. McClain C.J., Barve S.S., Barve A., et al. Alcoholic liver disease and malnutrition. Alcohol Clin Exp Res 2011, 35:815-820.
4. Achord J.L. Malnutrition and the role of nutritional support in alcoholic liver disease. Am J Gastroenterol 1987, 82:1-7.
5. Mendenhall C.L., Anderson S., Weesner R.E., et al. Protein-calorie malnutrition associated with alcoholic hepatitis. Veterans administration cooperative study group on alcoholic hepatitis. Am J Med 1984, 76:211-222.
6. DiCecco S.R., Wieners E.J., Wiesner R.H., et al. Assessment of nutritional status of patients with end-stage liver disease undergoing liver transplantation. Mayo Clin Proc 1989, 64:95-102.
7. Hehir D.J., Jenkins R.L., Bistrian B.R., et al. Nutrition in patients undergoing orthotopic liver transplant. JPEN J Parenter Enteral Nutr 1985, 9:695-700.
8. Roongpisuthipong C., Sobhonslidsuk A., Nantiruj K., et al. Nutritional assessment in various stages of liver cirrhosis. Nutrition 2001, 17:761-765.
9. Sarin S.K., Dhingra N., Bansal A., et al. Dietary and nutritional abnormalities in alcoholic liver disease: a comparison with chronic alcoholics without liver disease. Am J Gastroenterol 1997, 92:777-783.
10. Lolli R., Marchesini G., Bianchi G., et al. Anthropometric assessment of the nutritional status of patients with liver cirrhosis in an Italian population. Ital J Gastroenterol 1992, 24:429-435.
11. Carvalho L., Parise E.R. Evaluation of nutritional status of nonhospitalized patients with liver cirrhosis. Arq Gastroenterol 2006, 43:269-274.
12. Campillo B., Richardet J.P., Scherman E., et al. Evaluation of nutritional practice in hospitalized cirrhotic patients: results of a prospective study. Nutrition 2003, 19:515-521.
13. Rissanen A., Sarlio-Lahteenkorva S., Alfthan G., et al. Employed problem drinkers: a nutritional risk group?. Am J Clin Nutr 1987, 45:456-461.
14. Simko V., Connell A.M., Banks B. Nutritional status in alcoholics with and without liver disease. Am J Clin Nutr 1982, 35:197-203.
15. Sam J., Nguyen G.C. Protein-calorie malnutrition as a prognostic indicator of mortality among patients hospitalized with cirrhosis and portal hypertension. Liver Int 2009, 29:1396-1402.
16. Alvares-da-Silva M.R., Reverbel da Silveira T. Comparison between handgrip strength, subjective global assessment, and prognostic nutritional index in assessing malnutrition and predicting clinical outcome in cirrhotic outpatients. Nutrition 2005, 21:113-117.
17. Mendenhall C., Roselle G.A., Gartside P., et al. Relationship of protein calorie malnutrition to alcoholic liver disease: a reexamination of data from two Veterans Administration Cooperative Studies. Alcohol Clin Exp Res 1995, 19:635-641.
18. Stephenson G.R., Moretti E.W., El-Moalem H., et al. Malnutrition in liver transplant patients: preoperative subjective global assessment is predictive of outcome after liver transplantation. Transplantation 2001, 72:666-670.
19. Merli M., Giusto M., Gentili F., et al. Nutritional status: its influence on the outcome of patients undergoing liver transplantation. Liver Int 2010, 30:208-214.
20. Madden A.M., Bradbury W., Morgan M.Y. Taste perception in cirrhosis: its relationship to circulating micronutrients and food preferences. Hepatology 1997, 26:40-48.
21. Verne G.N., Soldevia-Pico C., Robinson M.E., et al. Autonomic dysfunction and gastroparesis in cirrhosis. J Clin Gastroenterol 2004, 38:72-76.
22. Aqel B.A., Scolapio J.S., Dickson R.C., et al. Contribution of ascites to impaired gastric function and nutritional intake in patients with cirrhosis and ascites. Clin Gastroenterol Hepatol 2005, 3:1095-1100.
23. Galati J.S., Holdeman K.P., Dalrymple G.V., et al. Delayed gastric emptying of both the liquid and solid components of a meal in chronic liver disease. Am J Gastroenterol 1994, 89:708-711.
24. Kalaitzakis E., Bosaeus I., Ohman L., et al. Altered postprandial glucose, insulin, leptin, and ghrelin in liver cirrhosis: correlations with energy intake and resting energy expenditure. Am J Clin Nutr 2007, 85:808-815.
25. Ockenga J., Bischoff S.C., Tillmann H.L., et al. Elevated bound leptin correlates with energy expenditure in cirrhotics. Gastroenterology 2000, 119:1656-1662.
26. Marchesini G., Bianchi G., Lucidi P., et al. Plasma ghrelin concentrations, food intake, and anorexia in liver failure. J Clin Endocrinol Metab 2004, 89:2136-2141.
27. Davcev P., Vanovski B., Sestakov D., et al. Protein-losing enteropathy in patients with liver cirrhosis. Digestion 1969, 2:17-22.
28. Roggin G.M., Iber F.L., Kater R.M., et al. Malabsorption in the chronic alcoholic. Johns Hopkins Med J 1969, 125:321-330.
29. Witte M.H., Dumont A.E., Cole W.R., et al. Lymph circulation in hepatic cirrhosis: effect of portacaval shunt. Ann Intern Med 1969, 70:303-310.
30. Dumont A.E., Witte C.L., Witte M.H. Protein content of liver lymph in patients with portal hypertension secondary to hepatic cirrhosis. Lymphology 1975, 8:111-113.
31. Smadja C., Franco D. Ann Gastroenterol Hepatol (Paris) 1988, 24:357-361. [in French].
32. Georgopoulos P., Mowat C., McMillan D.C., et al. Is portal hypertension associated with protein-losing enteropathy?. J Gastroenterol Hepatol 2005, 20:103-107.
33. Morgan M.Y. Enteral nutrition in chronic liver disease. Acta Chir Scand Suppl 1981, 507:81-90.
34. Thuluvath P.J., Triger D.R. Autonomic neuropathy and chronic liver disease. Q J Med 1989, 72:737-747.
35. Rodrigo C., Antezana C., Baraona E. Fat and nitrogen balances in rats with alcohol-induced fatty liver. J Nutr 1971, 101:1307-1310.
36. Leevy C.M., Moroianu S.A. Nutritional aspects of alcoholic liver disease. Clin Liver Dis 2005, 9:67-81.
37. Charlton M.R., Adey D.B., Nair K.S. Evidence for a catabolic role of glucagon during an amino acid load. J Clin Invest 1996, 98:90-99.
38. Petrides A.S., De Fronzo R.A. Failure of glucagon to stimulate hepatic glycogenolysis in well-nourished patients with mild cirrhosis. Metabolism 1994, 43:85-89.
39. Caufriez A., Reding P., Urbain D., et al. Insulin-like growth factor I: a good indicator of functional hepatocellular capacity in alcoholic liver cirrhosis. J Endocrinol Invest 1991, 14:317-321.
40. Wu J.C., Daughaday W.H., Lee S.D., et al. Radioimmunoassay of serum IGF-I and IGF-II in patients with chronic liver diseases and hepatocellular carcinoma with or without hypoglycemia. J Lab Clin Med 1988, 112:589-594.
41. Lieber C.S. The influence of alcohol on nutritional status. Nutr Rev 1988, 46:241-254.
42. Dudrick S.J., Kavic S.M. Hepatobiliary nutrition: history and future. J Hepatobiliary Pancreat Surg 2002, 9:459-468.
43. Cascino A., Cangiano C., Fiaccadori F., et al. Plasma and cerebrospinal fluid amino acid patterns in hepatic encephalopathy. Dig Dis Sci 1982, 27:828-832.
44. Marchesini G., Zoli M., Dondi C., et al. Prevalence of subclinical hepatic encephalopathy in cirrhotics and relationship to plasma amino acid imbalance. Dig Dis Sci 1980, 25:763-768.
45. McCullough A.J. Malnutrition in liver disease. Liver Transpl 2000, (4 Suppl 1):S85-S96.
46. Cabre E., Hernandez-Perez J.M., Fluvia L., et al. Absorption and transport of dietary long-chain fatty acids in cirrhosis: a stable-isotope-tracing study. Am J Clin Nutr 2005, 81:692-701.
47. Changani K.K., Jalan R., Cox I.J., et al. Evidence for altered hepatic gluconeogenesis in patients with cirrhosis using in vivo 31-phosphorus magnetic resonance spectroscopy. Gut 2001, 49:557-564.
48. Petrides A.S., Luzi L., Reuben A., et al. Effect of insulin and plasma amino acid concentration on leucine metabolism in cirrhosis. Hepatology 1991, 14:432-441.
49. Merli M., Leonetti F., Riggio O., et al. Glucose intolerance and insulin resistance in cirrhosis are normalized after liver transplantation. Hepatology 1999, 30:649-654.
50. Muller M.J., Lautz H.U., Plogmann B., et al. Energy expenditure and substrate oxidation in patients with cirrhosis: the impact of cause, clinical staging and nutritional state. Hepatology 1992, 15:782-794.
51. Reinus J.F., Heymsfield S.B., Wiskind R., et al. Ethanol: relative fuel value and metabolic effects in vivo. Metabolism 1989, 38:125-135.
52. Lieber C.S. ALCOHOL: its metabolism and interaction with nutrients. Annu Rev Nutr 2000, 20:395-430.
53. Bjarnason I., Peters T.J., Wise R.J. The leaky gut of alcoholism: possible route of entry for toxic compounds. Lancet 1984, 1:179-182.
54. McClain C.J., Barve S., Deaciuc I., et al. Cytokines in alcoholic liver disease. Semin Liver Dis 1999, 19:205-219.
55. Braillon A., Gaudin C., Poo J.L., et al. Plasma catecholamine concentrations are a reliable index of sympathetic vascular tone in patients with cirrhosis. Hepatology 1992, 15:58-62.
56. Singal A.K., Shah V.H. Alcoholic hepatitis: prognostic models and treatment. Gastroenterol Clin North Am 2011, 40:611-639.
57. Lucey M.R., Mathurin P., Morgan T.R. Alcoholic hepatitis. N Engl J Med 2009, 360:2758-2769.
58. Dolz C., Raurich J.M., Ibanez J., et al. Ascites increases the resting energy expenditure in liver cirrhosis. Gastroenterology 1991, 100:738-744.
59. Halsted C.H. Nutrition and alcoholic liver disease. Semin Liver Dis 2004, 24:289-304.
60. Detsky A.S., McLaughlin J.R., Baker J.P., et al. What is subjective global assessment of nutritional status?. JPEN J Parenter Enteral Nutr 1987, 11:8-13.
61. Pikul J., Sharpe M.D., Lowndes R., et al. Degree of preoperative malnutrition is predictive of postoperative morbidity and mortality in liver transplant recipients. Transplantation 1994, 57:469-472.
62. DiCecco S.R., Francisco-Ziller N. Nutrition in alcoholic liver disease. Nutr Clin Pract 2006, 21:245-254.
63. Nielsen K., Kondrup J., Martinsen L., et al. Nutritional assessment and adequacy of dietary intake in hospitalized patients with alcoholic liver cirrhosis. Br J Nutr 1993, 69:665-679.
64. Figueiredo F.A., Dickson E.R., Pasha T.M., et al. Utility of standard nutritional parameters in detecting body cell mass depletion in patients with end-stage liver disease. Liver Transpl 2000, 6:575-581.
65. Frisancho A.R. New norms of upper limb fat and muscle areas for assessment of nutritional status. Am J Clin Nutr 1981, 34:2540-2545.
66. Schlussel M.M., dos Anjos L.A., de Vasconcellos M.T., et al. Reference values of handgrip dynamometry of healthy adults: a population-based study. Clin Nutr 2008, 27:601-607.
67. Andersen H., Borre M., Jakobsen J., et al. Decreased muscle strength in patients with alcoholic liver cirrhosis in relation to nutritional status, alcohol abstinence, liver function, and neuropathy. Hepatology 1998, 27:1200-1206.
68. Mendenhall C.L., Chernausek S.D., Ray M.B., et al. The interactions of insulin-like growth factor I(IGF-I) with protein-calorie malnutrition in patients with alcoholic liver disease: V.A. Cooperative Study on Alcoholic Hepatitis VI. Alcohol Alcohol 1989, 24:319-329.
69. Englesbe M.J., Patel S.P., He K., et al. Sarcopenia and mortality after liver transplantation. J Am Coll Surg 2010, 211:271-278.
70. Prijatmoko D., Strauss B.J., Lambert J.R., et al. Early detection of protein depletion in alcoholic cirrhosis: role of body composition analysis. Gastroenterology 1993, 105:1839-1845.
71. Plauth M., Cabre E., Riggio O., et al. ESPEN guidelines on enteral nutrition: liver disease. Clin Nutr 2006, 25:285-294.
72. Pirlich M., Schutz T., Spachos T., et al. Bioelectrical impedance analysis is a useful bedside technique to assess malnutrition in cirrhotic patients with and without ascites. Hepatology 2000, 32:1208-1215.
73. Selberg O., Bottcher J., Tusch G., et al. Identification of high- and low-risk patients before liver transplantation: a prospective cohort study of nutritional and metabolic parameters in 150 patients. Hepatology 1997, 25:652-657.
74. Figueiredo F., Dickson E.R., Pasha T., et al. Impact of nutritional status on outcomes after liver transplantation. Transplantation 2000, 70:1347-1352.
75. Mullen J.L. Consequences of malnutrition in the surgical patient. Surg Clin North Am 1981, 61:465-487.
76. Shanbhogue R.L., Bistrian B.R., Jenkins R.L., et al. Resting energy expenditure in patients with end-stage liver disease and in normal population. JPEN J Parenter Enteral Nutr 1987, 11:305-308.
77. Swart G.R., Zillikens M.C., van Vuure J.K., et al. Effect of a late evening meal on nitrogen balance in patients with cirrhosis of the liver. BMJ 1989, 299:1202-1203.
78. Plank L.D., Gane E.J., Peng S., et al. Nocturnal nutritional supplementation improves total body protein status of patients with liver cirrhosis: a randomized 12-month trial. Hepatology 2008, 48:557-566.
79. Cordoba J., Lopez-Hellin J., Planas M., et al. Normal protein diet for episodic hepatic encephalopathy: results of a randomized study. J Hepatol 2004, 41:38-43.
80. Mullen K.D., Dasarathy S. Protein restriction in hepatic encephalopathy: necessary evil or illogical dogma?. J Hepatol 2004, 41:147-148.
81. Teratani T., Tomita K., Suzuki T., et al. A high-cholesterol diet exacerbates liver fibrosis in mice via accumulation of free cholesterol in hepatic stellate cells. Gastroenterology 2012, 142:152-164.e10.
82. Ioannou G.N., Morrow O.B., Connole M.L., et al. Association between dietary nutrient composition and the incidence of cirrhosis or liver cancer in the United States population. Hepatology 2009, 50:175-184.
83. Ekstedt M., Franzen L.E., Mathiesen U.L., et al. Statins in non-alcoholic fatty liver disease and chronically elevated liver enzymes: a histopathological follow-up study. J Hepatol 2007, 47:135-141.
84. Battistella F.D., Widergren J.T., Anderson J.T., et al. A prospective, randomized trial of intravenous fat emulsion administration in trauma victims requiring total parenteral nutrition. J Trauma 1997, 43:52-58. [discussion: 8-60].
85. Stickel F., Kessebohm K., Weimann R., et al. Review of liver injury associated with dietary supplements. Liver Int 2011, 31:595-605.
86. Lundbom N., Laurila O., Laurila S. Central pontine myelinolysis after correction of chronic hyponatraemia. Lancet 1993, 342:247-248.
87. de Ledinghen V., Beau P., Mannant P.R., et al. Early feeding or enteral nutrition in patients with cirrhosis after bleeding from esophageal varices? A randomized controlled study. Dig Dis Sci 1997, 42:536-541.
88. Baltz J.G., Argo C.K., Al-Osaimi A.M., et al. Mortality after percutaneous endoscopic gastrostomy in patients with cirrhosis: a case series. Gastrointest Endosc 2010, 72:1072-1075.
89. Calvey H., Davis M., Williams R. Controlled trial of nutritional supplementation, with and without branched chain amino acid enrichment, in treatment of acute alcoholic hepatitis. J Hepatol 1985, 1:141-151.
90. Mendenhall C., Bongiovanni G., Goldberg S., et al. VA Cooperative Study on Alcoholic Hepatitis. III: changes in protein-calorie malnutrition associated with 30 days of hospitalization with and without enteral nutritional therapy. JPEN J Parenter Enteral Nutr 1985, 9:590-596.
91. Mendenhall C.L., Moritz T.E., Roselle G.A., et al. A study of oral nutritional support with oxandrolone in malnourished patients with alcoholic hepatitis: results of a Department of Veterans Affairs cooperative study. Hepatology 1993, 17:564-576.
92. Cabre E., Rodriguez-Iglesias P., Caballeria J., et al. Short- and long-term outcome of severe alcohol-induced hepatitis treated with steroids or enteral nutrition: a multicenter randomized trial. Hepatology 2000, 32:36-42.
93. Moreno C., Langlet P., Hittelet A., et al. Enteral nutrition with or without N-acetylcysteine in the treatment of severe acute alcoholic hepatitis: a randomized multicenter controlled trial. J Hepatol 2010, 53:1117-1122.
94. Alvarez M.A., Cabre E., Lorenzo-Zuniga V., et al. Combining steroids with enteral nutrition: a better therapeutic strategy for severe alcoholic hepatitis? Results of a pilot study. Eur J Gastroenterol Hepatol 2004, 16:1375-1380.
95. Bunout D., Aicardi V., Hirsch S., et al. Nutritional support in hospitalized patients with alcoholic liver disease. Eur J Clin Nutr 1989, 43:615-621.
96. Cabre E., Gonzalez-Huix F., Abad-Lacruz A., et al. Effect of total enteral nutrition on the short-term outcome of severely malnourished cirrhotics. A randomized controlled trial. Gastroenterology 1990, 98:715-720.
97. Hirsch S., Bunout D., de la Maza P., et al. Controlled trial on nutrition supplementation in outpatients with symptomatic alcoholic cirrhosis. JPEN J Parenter Enteral Nutr 1993, 17:119-124.
98. Kearns P.J., Young H., Garcia G., et al. Accelerated improvement of alcoholic liver disease with enteral nutrition. Gastroenterology 1992, 102:200-205.
99. Dupont B., Dao T., Joubert C., et al. Randomised clinical trial: enteral nutrition does not improve the long-term outcome of alcoholic cirrhotic patients with jaundice. Aliment Pharmacol Ther 2012, 35(10):1166-1174.
100. Plauth M., Cabre E., Campillo B., et al. ESPEN Guidelines on parenteral nutrition: hepatology. Clin Nutr 2009, 28:436-444.
101. Galambos J.T., Hersh T., Fulenwider J.T., et al. Hyperalimentation in alcoholic hepatitis. Am J Gastroenterol 1979, 72:535-541.
102. Nasrallah S.M., Galambos J.T. Aminoacid therapy of alcoholic hepatitis. Lancet 1980, 2:1276-1277.
103. Diehl A.M., Boitnott J.K., Herlong H.F., et al. Effect of parenteral amino acid supplementation in alcoholic hepatitis. Hepatology 1985, 5:57-63.
104. Naveau S., Pelletier G., Poynard T., et al. A randomized clinical trial of supplementary parenteral nutrition in jaundiced alcoholic cirrhotic patients. Hepatology 1986, 6:270-274.
105. Achord J.L. A prospective randomized clinical trial of peripheral amino acid-glucose supplementation in acute alcoholic hepatitis. Am J Gastroenterol 1987, 82:871-875.
106. Simon D., Galambos J.T. A randomized controlled study of peripheral parenteral nutrition in moderate and severe alcoholic hepatitis. J Hepatol 1988, 7:200-207.
107. Mezey E., Caballeria J., Mitchell M.C., et al. Effect of parenteral amino acid supplementation on short-term and long-term outcomes in severe alcoholic hepatitis: a randomized controlled trial. Hepatology 1991, 14:1090-1096.
108. Charlton M. Branched-chain amino acid-enriched supplements as therapy for liver disease: Rasputin lives. Gastroenterology 2003, 124:1980-1982.
109. Horst D., Grace N.D., Conn H.O., et al. Comparison of dietary protein with an oral, branched chain-enriched amino acid supplement in chronic portal-systemic encephalopathy: a randomized controlled trial. Hepatology 1984, 4:279-287.
110. Christie M.L., Sack D.M., Pomposelli J., et al. Enriched branched-chain amino acid formula versus a casein-based supplement in the treatment of cirrhosis. JPEN J Parenter Enteral Nutr 1985, 9:671-678.
111. McGhee A., Henderson J.M., Millikan W.J., et al. Comparison of the effects of Hepatic-Aid and a Casein modular diet on encephalopathy, plasma amino acids, and nitrogen balance in cirrhotic patients. Ann Surg 1983, 197:288-293.
112. Yoshida T., Muto Y., Moriwaki H., et al. Effect of long-term oral supplementation with branched-chain amino acid granules on the prognosis of liver cirrhosis. Gastroenterol Jpn 1989, 24:692-698.
113. Marchesini G., Bianchi G., Merli M., et al. Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind, randomized trial. Gastroenterology 2003, 124:1792-1801.
114. Muto Y., Sato S., Watanabe A., et al. Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis. Clin Gastroenterol Hepatol 2005, 3:705-713.
115. Charlton M. Branched-chain amino-acid granules: can they improve survival in patients with liver cirrhosis?. Nat Clin Pract Gastroenterol Hepatol 2006, 3:72-73.
116. Dey A., Cederbaum A.I. Alcohol and oxidative liver injury. Hepatology 2006, 43:S63-S74.
117. Singal A.K., Jampana S.C., Weinman S.A. Antioxidants as therapeutic agents for liver disease. Liver Int 2011, 31:1432-1448.
118. Singal A.K., Walia I., Singal A., et al. Corticosteroids and pentoxifylline for the treatment of alcoholic hepatitis: current status. World J Hepatol 2011, 3:205-210.
119. Phillips M., Curtis H., Portmann B., et al. Antioxidants versus corticosteroids in the treatment of severe alcoholic hepatitis-a randomised clinical trial. J Hepatol 2006, 44:784-790.
120. Mezey E., Potter J.J., Rennie-Tankersley L., et al. A randomized placebo controlled trial of vitamin E for alcoholic hepatitis. J Hepatol 2004, 40:40-46.
121. de la Maza M.P., Petermann M., Bunout D., et al. Effects of long-term vitamin E supplementation in alcoholic cirrhotics. J Am Coll Nutr 1995, 14:192-196.
122. Lieber C.S., Weiss D.G., Groszmann R., et al. Veterans Affairs Cooperative Study of polyenylphosphatidylcholine in alcoholic liver disease. Alcohol Clin Exp Res 2003, 27:1765-1772.
123. Ruhl C.E., Everhart J.E. Coffee and tea consumption are associated with a lower incidence of chronic liver disease in the United States. Gastroenterology 2005, 129:1928-1936.
124. Klatsky A.L., Armstrong M.A. Alcohol, smoking, coffee, and cirrhosis. Am J Epidemiol 1992, 136:1248-1257.
125. Freedman N.D., Park Y., Abnet C.C., et al. Association of coffee drinking with total and cause-specific mortality. N Engl J Med 2012, 366:1891-1904.
126. Tverdal A., Skurtveit S. Coffee intake and mortality from liver cirrhosis. Ann Epidemiol 2003, 13:419-423.
127. Bonkovsky H.L., Fiellin D.A., Smith G.S., et al. A randomized, controlled trial of treatment of alcoholic hepatitis with parenteral nutrition and oxandrolone. I. Short-term effects on liver function. Am J Gastroenterol 1991, 86:1200-1208.